HEMImprove 1.0 in Children and Adolescents With Unilateral Cerebral Palsy
NCT ID: NCT07041944
Last Updated: 2025-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
36 participants
INTERVENTIONAL
2025-09-01
2026-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Motor and Cognitive Function on Unilateral Spastic Cerebral Palsy, Associated With Videogame Therapy
NCT05557305
Impact of Somatosensory Intensive Intervention on Motor Performance in Children With Unilateral Cerebral Palsy
NCT04235088
Constraint Induced Movement Therapy on Infantile Hemiplegia
NCT02178371
The Efficacy of Two Models of Intensive Upper Limb Training on Quality of Life in Children With Congenital Hemiplegia
NCT04425980
Upper Limb Somatosensory Discrimination Therapy and Dose-matched Motor Therapy in Children and Adolescents With Unilateral Cerebral Palsy
NCT06006065
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HEMImprove APP
Experimental Group:
Use HEMImprove 1.0 mobile app at home for 30 minutes/session, 5 days/week, for 4 weeks. Exercises tailored progressively with avatar guidance.
Control Group:
Perform conventional home exercises guided by printed manual with instructions and images, matching frequency and duration of intervention group.
HEMImprove APP
Experimental Group:
Use HEMImprove 1.0 mobile app at home for 30 minutes/session, 5 days/week, for 4 weeks. Exercises tailored progressively with avatar guidance.
Control Group:
Perform conventional home exercises guided by printed manual with instructions and images, matching frequency and duration of intervention group.
Control group
The control group will do exercises for the same time that is described in the experimental group, without using the APP
exercises to upper limb
The patients will do the same exercises than the experimental group, without APP and using the same dosage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HEMImprove APP
Experimental Group:
Use HEMImprove 1.0 mobile app at home for 30 minutes/session, 5 days/week, for 4 weeks. Exercises tailored progressively with avatar guidance.
Control Group:
Perform conventional home exercises guided by printed manual with instructions and images, matching frequency and duration of intervention group.
exercises to upper limb
The patients will do the same exercises than the experimental group, without APP and using the same dosage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to use the mobile app independently or with minimal assistance.
* Informed consent provided.
Exclusion Criteria
* Recent upper limb surgery (within 6 months).
* Recent botulinum toxin treatment (within 3 months).
* Other neurological or orthopedic disorders affecting upper limb function.
12 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Castilla-La Mancha
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FEDER
Identifier Type: OTHER
Identifier Source: secondary_id
HEMImprove-APP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.